|
Volumn , Issue 35, 2005, Pages 113-115
|
Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ESTROGEN;
GESTAGEN;
PROGESTERONE DERIVATIVE;
ARTICLE;
BREAST TUMOR;
CEREBROVASCULAR ACCIDENT;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DRUG EFFECT;
ESTROGEN THERAPY;
EVIDENCE BASED MEDICINE;
FEMALE;
HEALTH SERVICE;
HEART DISEASE;
HUMAN;
MULTICENTER STUDY;
POSTMENOPAUSE;
PSYCHOLOGICAL ASPECT;
RISK FACTOR;
STANDARD;
UTILIZATION REVIEW;
WOMEN'S HEALTH;
BREAST NEOPLASMS;
CEREBROVASCULAR ACCIDENT;
ESTROGEN REPLACEMENT THERAPY;
ESTROGENS;
EVIDENCE-BASED MEDICINE;
FEMALE;
HEALTH SERVICES;
HEART DISEASES;
HUMANS;
POSTMENOPAUSE;
PROGESTERONE CONGENERS;
PROGESTINS;
RISK FACTORS;
WOMEN'S HEALTH;
|
EID: 33644799449
PISSN: 10526773
EISSN: None
Source Type: Journal
DOI: 10.1093/jncimonographs/lgi048 Document Type: Article |
Times cited : (12)
|
References (0)
|